|
|
| | N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-((2-methylpiperidin-1-yl)sulfonyl)benzamide Basic information |
| | N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-((2-methylpiperidin-1-yl)sulfonyl)benzamide Chemical Properties |
| density | 1.390±0.06 g/cm3(Predicted) | | pka | 10.02±0.70(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-((2-methylpiperidin-1-yl)sulfonyl)benzamide Usage And Synthesis |
| Uses | 1650-M15 is an inhibitor of lipoteichoic acid synthase (LtaS). It has inhibitory activity against Gram-positive bacteria but has no significant inhibitory effect against Gram-negative bacteria. The IC50s of 1650-M15 against MRSA and MSSA are 62.44 μM and 66.42 μM, respectively, and the MICs are both 200 μM[1]. | | References | [1] Methods and compositions for inhibiting gram positive bacteria. United States, US20150246024 A1, 2015-09-03. |
| | N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-((2-methylpiperidin-1-yl)sulfonyl)benzamide Preparation Products And Raw materials |
|